According to the immunohistochemical results, the Ki-67 and PCNA levels in the primary tumor tissues were markedly reduced in the 89-treated group, indicating the inhibition of 89 against the tumor cell proliferation in vivo (Fig. 7D). This evidence concerns the gene PCNA and neoplasm.